Available IPD datapackage for study 'Phase II Study Of Single-Agent SU011248 In The Treatment Of Patients With Renal Cell Carcinoma'
收藏DataCite Commons2025-07-07 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/dataPackages/PR00006802.1
下载链接
链接失效反馈官方服务：
资源简介：
To determine the objective tumor response of single-agent SU011248 at a dose of 50 mg orally
once daily for 4 consecutive weeks and 2 weeks rest, repeated every 6 weeks in patients with
metastatic Renal Cell Cancer (RCC).
提供机构：
Vivli
创建时间：
2025-07-07
